Additionally, in the FMT experiment, AA aggravated the brain inflammation of AD, while MA relieved the AD-induced inflammation through reducing the levels of inflammatory factors TNF-a and IL-1β in the brain (p < 0.05 and p < 0.01, respectively, Figure 7G). This evidence concerns the gene IL1B and Alzheimer disease.